Digostics, a UK-based diabetes home-testing provider, who graduated from our NHS Market Access Accelerator programme in 2022 have partnered with Medway NHS Foundation Trust to transform local gestational diabetes screening, by offering world-first home oral glucose tolerance testing (OGTT) technology to all at-risk women.
eMurmur, an Ontario-based artificial intelligence (AI) startup, has received U.S. Food and Drug Administration (FDA) clearance for its suite of algorithms designed to evaluate heart recordings captured by digital stethoscopes.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us